Mitomycin C–Assisted Photorefractive Keratectomy in High Myopia: A Long-term Safety Study

Abstract

Intraoperative use of topical 0.02% MMC compared with standard treatment does not induce significant long-term corneal changes, as assessed by in vivo corneal confocal microscopy.